Susoctocog-alfa (Obizur(®)) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience

BACKGROUND: In 2016, a new recombinant B-domain deleted porcine FVIII (rpFVIII) was licensed in Italy for the treatment of acquired haemophilia A (AHA), but only a few cases of patients receiving this have been reported in the literature. Here we report the largest registry of the use of rpFVIII for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Transfus
Autors principals: Zanon, Ezio, Pasca, Samantha, Borchiellini, Alessandra, Lodigiani, Corrado, Molinari, Angelo C., Ambaglio, Chiara, Valeri, Federica, Preti, Paola S., Moscatelli, Paolo, Simioni, Paolo
Format: Artigo
Idioma:Inglês
Publicat: Edizioni SIMTI - SIMTI Servizi Srl 2020
Matèries:
Haemostasis and Thrombosis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7375884/
https://ncbi.nlm.nih.gov/pubmed/32698943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2020.00006-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars